Cardiovascular Risk Markers in Hemodialysis Patients
暂无分享,去创建一个
[1] P. Tuppin,et al. Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[2] S. Lipsitz,et al. Serum cardiac troponin and subclinical cardiac status in pediatric chronic renal failure. , 2003, Pediatrics.
[3] Z. Massy. Potential strategies to normalize the levels of homocysteine in chronic renal failure patients. , 2003, Kidney international. Supplement.
[4] P. Stenvinkel,et al. Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[5] Fred S Apple,et al. Predictive Value of Cardiac Troponin I and T for Subsequent Death in End-Stage Renal Disease , 2002, Circulation.
[6] P. Stenvinkel,et al. Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] C. Enzinger,et al. Hyperhomocysteinemia, pteridines and oxidative stress. , 2002, Current drug metabolism.
[8] C. Zoccali,et al. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. , 2002, Kidney international.
[9] J. Selhub,et al. Treatment of hyperhomocysteinemia in end-stage renal disease. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] P O Collinson,et al. Measurement of Cardiac Troponins , 2001, Annals of clinical biochemistry.
[11] P. Tuppin,et al. Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis And New Cardiac Markers Evaluation (CHANCE) study. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] T. Meinertz,et al. Implications of troponin testing in clinical medicine , 2001, Current controlled trials in cardiovascular medicine.
[13] D. Wilcken,et al. Homocysteine and cardiovascular disease: cause or effect? , 2000, The American journal of clinical nutrition.
[14] S. Vollset,et al. The controversy over homocysteine and cardiovascular risk. , 2000, The American journal of clinical nutrition.
[15] Mohamed,et al. Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients. , 2000, Kidney international.
[16] A. Donker,et al. Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy. , 2000, Clinical Nephrology.
[17] S. K. George,et al. Current markers of myocardial ischemia and their validity in end-stage renal disease. , 1999, Current opinion in nephrology and hypertension.
[18] S. Morgan,et al. Cardiac troponin-I accurately predicts myocardial injury in renal failure. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[19] R. Solaro,et al. Troponin I, stunning, hypertrophy, and failure of the heart. , 1999, Circulation research.
[20] A. Donker,et al. The impact of an amino acid-based peritoneal dialysis fluid on plasma total homocysteine levels, lipid profile and body fat mass. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[21] J. Hegbrant,et al. Influence of haemodialysis on plasma total homocysteine concentration. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[22] P. Ueland,et al. Recent data are not in conflict with homocysteine as a cardiovascular risk factor. , 1998, Current opinion in lipidology.
[23] A. Collins,et al. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. , 1998, The New England journal of medicine.
[24] A. Donker,et al. Folic Acid Treatment of Hyperhomocysteinemia in Peritoneal Dialysis Patients: No Change in Endothelial Function after Long Term Therapy , 1998, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[25] G. Steinbach,et al. Specificity of Cardiac Troponins I and T in Renal Disease , 1998, Clinical chemistry and laboratory medicine.
[26] A. Bostom,et al. Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. , 1997, Kidney international.
[27] J. Witteman,et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. , 1997, JAMA.
[28] F. T. Stevenson,et al. Determinants of albumin concentration in hemodialysis patients. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[29] P. Jungers,et al. Hyperhomocysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients. , 1997, Mineral and electrolyte metabolism.
[30] P. Ueland. Plasma homocysteine as a risk factor for cardiovascular disease and as an indicator of vitamin deficiencies , 1996 .
[31] G. Omenn,et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.
[32] E. Livant,et al. Plasma folate conjugase activities and folate concentrations in patients receiving hemodialysis , 1994 .
[33] B. Pau,et al. Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction. , 1993, Clinical chemistry.
[34] S. Perry. The regulation of contractile activity in muscle. , 1979, Biochemical Society transactions.
[35] J. Wilkinson,et al. Comparison of amino acid sequence of troponin I from different striated muscles , 1978, Nature.
[36] I. Goldman,et al. Inhibition of the membrane transport of folates by anions retained in uremia. , 1975, The Journal of laboratory and clinical medicine.